De-differentiation of melanoma tumour cells has been associated with development of resistance to therapy.26,27 We evaluated the effect of BRAF and MEK inhibitors on the cell viability and cell death of C790 and 4434 partially reprogrammed cells. Here, BRAF is linked to melanoma.